MILLENNIUM MANAGEMENT LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1273087
NEW YORK, NY
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$38,491,498
-$8,289,657 QoQ
Shares Held
1,912,146
-34.0% QoQ
Ownership
3.59%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#10
of 182 holders
Holding Since
Jun 2020
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Derivatives in KALV
reported options exposure · as of Dec 31, 2025CallValue
$379,525
CallShares
23,500
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026MILLENNIUM MANAGEMENT LLC holds $4,570,822,033 across 342 Biotechnology names. KALV ranks #30 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
1,262,511 | $238,677,704 | |
| 2 | INSM |
INSMED Inc
|
1,157,786 | $189,321,166 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
3,010,308 | $170,052,298 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
|
3,011,558 | $158,769,337 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
447,887 | $148,192,371 | |
| 6 | FOLD |
AMICUS THERAPEUTICS, INC.
|
7,908,459 | $114,356,317 | |
| 7 | ARDX |
Ardelyx, Inc.
|
17,842,370 | $106,875,796 | |
| 8 | BLTE |
Belite Bio, Inc
|
570,088 | $90,894,830 |
All Filings in KALV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,491,498 | 1,912,146 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $379,525 | 23,500 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $46,781,155 | 2,896,666 | Shares | Sole | 2026-02-17 | |
| 2025-12-23 | $46,678,259 | 2,963,699 | Shares | Sole | 2025-12-30 | |
| 2025-11-04 | $27,233,667 | 2,531,010 | Shares | Sole | 2025-11-10 | |
| 2025-09-30 | $243,600 | 20,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $25,531,996 | 2,096,223 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,850,810 | 340,629 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $1,017,450 | 90,000 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $2,287,285 | 198,205 | Shares | Sole | 2025-05-15 | |
| 2024-03-31 | $229,241 | 19,329 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $612,500 | 50,000 | Put | Sole | 2024-02-14 | |
| 2023-06-30 | $251,415 | 27,935 | Shares | Sole | 2023-08-14 | |
| 2023-06-30 | $450,000 | 50,000 | Call | Sole | 2023-08-14 | |
| 2023-03-31 | $634,325 | 80,703 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $676,000 | 100,000 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | $3,219,456 | 476,251 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $6,935,170 | 477,958 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $987,119 | 100,317 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $252,761 | 17,148 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $640,676 | 36,715 | Shares | Sole | 2021-11-15 | |
| 2020-12-31 | $546,855 | 28,797 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $790,375 | 62,778 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $574,290 | 47,462 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||